Guidelines for the use of Sandimmun in nephrotic syndrome

Meyrier, A.; Niaudet, P.; Brodehl, J.

doi:10.1007/978-3-642-77310-5_6

A. Meyrier M.D.⁴,
P. Niaudet M.D.⁵ &
J. Brodehl M.D.⁶

38 Accesses

Abstract

Before prescribing Sandimmun, the physician should consider the general contraindications to its use as listed in the documents provided by Sandoz Pharma Ltd with the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Author information

Authors and Affiliations

Department of Nephrology and Hypertension Hôpital Avicenne Faculté de Médecine de Bobigny, Université Paris-Nord, Bobigny, France
A. Meyrier M.D. (Professor of Medicine)
Department of Nephrology, Hôpital Necker-Enfants-Malades, Paris, France
P. Niaudet M.D. (Professor of Pediatric Nephrology)
Department of Pediatric Nephrology, Medizinische Hochschule, Hannover, Germany
J. Brodehl M.D. (Professor of Medicine)

Authors

A. Meyrier M.D.
View author publications
You can also search for this author in PubMed Google Scholar
P. Niaudet M.D.
View author publications
You can also search for this author in PubMed Google Scholar
J. Brodehl M.D.
View author publications
You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Meyrier, A., Niaudet, P., Brodehl, J. (1992). Guidelines for the use of Sandimmun in nephrotic syndrome. In: Optimal Use of Sandimmun® in Nephrotic Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77310-5_6

Download citation

DOI: https://doi.org/10.1007/978-3-642-77310-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55180-5
Online ISBN: 978-3-642-77310-5
eBook Packages: Springer Book Archive

Publish with us

Policies and ethics